Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-10-19
1991-09-24
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514315, 514316, 514319, 514325, 514326, 514328, A61K 31445
Patent
active
050514075
ABSTRACT:
A method for treating a viral infection in a human or animal patient comprising administering to such patient an antivirally effective amount of a substituted hydroxypiperidine, namely a 2-hydroxymethylene-3,4,5-trihydroxypiperidine.
REFERENCES:
patent: 4260622 (1981-04-01), Junge et al.
patent: 4293551 (1981-10-01), Kinast et al.
patent: 4328233 (1982-05-01), Boshagen et al.
patent: 4407809 (1983-10-01), Junge et al.
patent: 4894366 (1990-01-01), Okuhara et al.
Nature, vol. 322, Jul. 1986, "Pathogenesis of Lentivirus Infections", pp. 130-136.
Antimicrobial Agents & Chemotherapy, Sep. 1987, pp. 1369-1374, vol. 31, No. 9, "Visna Virus as an In Vitro . . . 2',3'-Dideoxynucleosides".
Journal of Virology, May 1987, pp. 1325-1331, vol. 61, No. 5, "Visna Virus Exhibits . . . Syndrome Retrovirus".
Proc. Natl. Acad. Sci. USA, vol. 86, pp. 414-418, Jan. 1989, Biochemistry, "Characterization of a cDNA . . . Protein".
"A Comparative Analysis of the . . . Syndrome Lentiviruses", 1986, pp. 339-343.
Science, vol. 229, "Cis- and Trans-Acting Transcriptional Regulation of the Visna Virus", pp. 482-485.
Cell, vol. 42, pp. 369-382, Aug. 1985, "Nucleotide Squences of the Visna Lentivirus: Relationship to the AIDS Virus".
Science, vol. 227, Jan. 1985, pp. 173-177, "Sequence Homology . . . a Pathogenic Lentivirus".
Proc. Natl. Acad. Sci., vol. 82, pp. 7096-7100, Oct. 1985; Medical Sciences; 3'-Azido-3'-deoxythymidine (BW A509U); An Antiviral Agent that Inhibits the Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in Vitro; Hiroaki Mitsuya et al.
Macmillan Journals Ltd., 1987, vol. 325, No. 6107, pp. 773-778; Strategies for Antiviral Therapy in AIDS; Hiroaki Mitsuya et al.
Drugs Reviews; vol. 6, Dec. 1987, Clinical Pharmacy, pp. 927-939; Development of Antiviral Agents for the Treatment of Human Immunodeficiency Virus Infection; Teresa A. Tartaglione and Ann C. Collier.
The Lancet, May 27, 1989; p. 1206; Anti-HIV Activity of Castanospermine Analogues.
Fifteenth Edition, The Merck Manual of Diagnosis and Therapy, Berkow et al., Published by Merck Sharp & Dohme Research Laboratories, Rahway, N.J., 1987, pp. 158-168.
Boshagen Horst
Junge Bodo
Kinast Gunther
Paessens Arnold
Schuller Matthias
Bayer Aktiengesellschaft
Griffin Ronald W.
LandOfFree
Methods for treating viruses in patients by administering 2-hydr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating viruses in patients by administering 2-hydr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating viruses in patients by administering 2-hydr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1696697